ABT   $117.56  1.00% Market Open

Abbott Laboratories
Total Cash 7.22B
totalCashPerShare 4.149
EBITDA 10.57B
Total Debt 14.84B
quickRatio 1.023
currentRatio 1.68
Total Revenue 40.73B
debtToEquity 37.525
Revenue/Share 23.402
ROA 0.06255
ROE 0.14441
grossProfits
freeCashflow 5.39B
operatingCashflow 7.90B
earningsGrowth -0.05
revenueGrowth 0.04
grossMargins 0.55474997
ebitdaMargins 0.25957
operatingMargins 0.17663999
profitMargins 0.13645001
enterpriseValue 210.39B
forwardPE 22.645916
floatShares 1.73B
sharesOutstanding 1.74B
sharesShort 12.75M
sharesShortPriorMonth 13.63M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.78%
Short Ratio help_outline 2.30%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 22.598
Price To Book help_outline 5.15
earningsQuarterlyGrowth -0.05
netIncomeToCommon 5.54B
trailingEps 3.17%
forwardEps 5.14%
enterpriseToEbitda 19.90
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.2 3Q 2024
institutionsCount 3572
lastUpdated Sept. 16, 2024, 11:46 a.m.